Valuation: Jerusalem Pharmaceuticals Co. Ltd.

Market Cap 122M 109M 101M 91.51M 171M 11.62B 174M 1.22B 481M 6.09B 459M 450M 19.19B P/E 2024
13.7x
P/E 2025 8.13x
Enterprise Value 112M 99.57M 91.99M 83.36M 156M 10.58B 159M 1.11B 438M 5.55B 418M 410M 17.48B EV / Sales 2024
1.47x
EV / Sales 2025 1.47x
Free-Float
34.87%
Yield 2024
2.09%
Yield 2025 3.26%
1 day+0.59%
1 week-3.68%
Current month-3.68%
1 month-2.86%
3 months-4.76%
6 months-10.76%
Current year+47.83%
1 week 3.38
Extreme 3.38
3.45
1 month 3.36
Extreme 3.36
3.6
Current year 2.28
Extreme 2.285
4
1 year 2
Extreme 2
4
3 years 1.74
Extreme 1.745
4
5 years 1.36
Extreme 1.355
4
10 years 0.8
Extreme 0.795
4
Manager TitleAgeSince
Chief Executive Officer - 2013-06-30
Director of Finance/CFO - 2020-02-29
Chief Tech/Sci/R&D Officer - 1988-12-31
Director TitleAgeSince
Chairman 91 -
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+0.59%-3.68%+70.00%+82.31% 122M
-2.54%+1.31%+54.27%+117.14% 1,135B
-1.42%+3.23%+38.56%+74.05% 635B
+0.16%+0.08%+25.29%+96.64% 505B
-0.31%+3.09%+44.14%+64.55% 378B
-1.34%-0.47%+66.04%+40.18% 358B
-0.68%+2.65%+22.98%+49.15% 295B
-1.20%+3.04%+2.33%+21.60% 266B
-1.79%+1.57%+50.56%+61.40% 237B
-0.73%-0.10%+29.02%+99.06% 193B
Average -0.93%+1.07%+40.32%+70.61% 400.38B
Weighted average by Cap. -1.35%+1.63%+41.02%+80.33%

Financials

2024 2025
Net sales 39.82M 35.56M 32.85M 29.77M 55.7M 3.78B 56.62M 395M 157M 1.98B 149M 146M 6.24B 48.95M 43.71M 40.38M 36.59M 68.46M 4.65B 69.59M 486M 192M 2.43B 184M 180M 7.67B
Net income 5.04M 4.5M 4.16M 3.77M 7.05M 478M 7.16M 50.01M 19.8M 251M 18.91M 18.5M 790M 10.18M 9.09M 8.4M 7.61M 14.24M 967M 14.48M 101M 40.02M 506M 38.22M 37.4M 1.6B
Net Debt -10.32M -9.22M -8.52M -7.72M -14.44M -980M -14.68M -102M -40.57M -513M -38.74M -37.91M -1.62B -10.9M -9.73M -8.99M -8.15M -15.24M -1.03B -15.49M -108M -42.83M -542M -40.89M -40.02M -1.71B
Projected Income Statement - Annual - Jerusalem Pharmaceuticals Co. Ltd.
Logo Jerusalem Pharmaceuticals Co. Ltd.
Jerusalem Pharmaceuticals Co Ltd (Al-Quds) is a Palestine-based public shareholding company engaged in the manufacture and trade of pharmaceutical, veterinary, detergent, and cosmetics products. Its product range spans the whole spectrum of ethical pharmaceuticals, as well as over the counter preparations and nutritional supplements. Its Products are presented in different dosage forms such as tablets, capsules, ampoules, granules and powders for suspensions, suspensions, syrups, lotions, powders, suppositories, ovules, creams, ointments, gels, emulgels, ear, eye and nose drops, solutions, mouth rinse and gargles. The Company also produces veterinary products including vials, powders, oral liquids and fodder additives such as multivitamins and multi-minerals. It also manufactures detergents and cosmetics under license from French companies. The Company operates three production facilities include Factory for General Production, Penicillin Factory and Cephalosporin Factory.
Employees
595
Date Price Change Volume
26-10-25 US$3.400 +0.59% 9,200
26-10-22 US$3.380 -2.03% 1,079
26-10-21 US$3.450 +2.68% 20